Obesity Medicine Doctor Contributes Diabetes Op-ed

A Long Island Business News (LIBN) op-ed by Eleanor Yusupov, D.O., assistant professor at NYITCOM, advises diabetes patients to heed the FDA’s warning against using smartwatches or smart rings to measure blood glucose levels. Yusupov, an obesity medicine physician and diabetes expert, notes that these devices are not FDA-approved for blood glucose monitoring and that relying on them to do so could be deadly. Instead, she advises diabetes patients to use minimally invasive continuous glucose monitors (CGMs), some of which can send results to smartphones or smartwatches and even be programmed to alert the patient if blood sugar levels become dangerously high or low.

“The bottom line: relying on devices that claim to measure blood glucose without getting under the skin can be deadly. If you want to view results on a smart device, pair it to a CGM instead,” writes Yusupov.